14. Hydrocodone and Acetaminophen tablet 2.5mg/325mg, 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets Norco Pain $700 million
15. Hydromorphone Hydrochloride non-AD 8 mg Tablets Dilaudid® Pain off line
$ GENERIC PIPELINE $$$$
16. ELI-300 Opioid Undisclosed Pain Early Development
17. ELI-301 Opioid Undisclosed Pain Early development
18. Codeine and Acetaminophen tablet Pain Generic Tylenol APAP Filed Pending FDA Approval
19. SunGen ANDA #2 ———ELITE’S NEW AVATAR $1.6 Billion Dollar Market——— Undisclosed ER CNS Stimulant 4 Competitors which includes the name brand Filed and under FDA Review 10-12 months from Approval Concerta ANDA
20. Elite/SunGen Generic #3 $110 million market Undisclosed IR Antibiotic In Development
21. Elite/SunGen Generic #4 Undisclosed Anti-depressant In Development
22. SunGen ANDA #5 Elites MONSTER ANDA it is Bigger than SunGen ANDA #2 Undisclosed CNS stimulant market greater than $1.6 Billion Will be filed first half 2019, largest SunGen product to date
23. Elite/SunGen Generic #6 Undisclosed Antibiotic In Development
24. Elite/SunGen Generic #7 Undisclosed Antibiotic In Development
25. Elite/SunGen Generic #8 Undisclosed Antispasmodic In Development
26. ELI-201 Generic ER Opioid Troxyca equivalent Pain Waiting for FDA guidance for an equivalent comparator
27. Generic Embeda Needs to be filed ASAP may be undisclosed Pain